Atlas Trials

Postoperative Immunotherapy vs Standard Chemotherapy for Gastric Cancer With High Risk for Recurrence

Clinical trial NCT03443856 · UNKNOWN

Trial details

NCT number
NCT03443856
Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Gastric and Esophagogastric Junction Adenocarcinoma
Start date
2019-07-17
Primary completion
2023-12-12
Enrollment
197

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.